A novel EGFR mutation in exon 19 showed stable disease after TKI treatment.
Anthonie J
AJ
van der Wekken
Jos A
JA
Stigt
Nils
N
A't Hart
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D020125:Mutation, Missense / Q000235:genetics*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors